Posted on 5/18/20
Better Coronavirus Stock: Johnson & Johnson or Emergent BioSolutions?
Any list of companies in the thick of the battle against novel coronavirus disease COVID-19 absolutely needs to include Johnson & Johnson (NYSE:JNJ) and Emergent BioSolutions . . .
Posted on 5/18/20
Better Buy: Pfizer vs. Bristol Myers Squibb
The times they are a-changin' for two big drugmakers. Pfizer (NYSE:PFE) will look like a much different company within a few months as it spins off . . .
Posted on 5/18/20
Bristol Myers Squibb's Cancer Combo Gets a Green Light from the FDA
Lung cancer patients in advanced stages of the disease received a new first-line treatment option on Friday. The FDA has approved the combination of Opdivo plus . . .
Posted on 5/18/20
Pfizer Posts Positive Data from Duchenne Muscular Dystrophy Candidate, but Still Trails Rival Sarepta Therapeutics
Pfizer (NYSE:PFE) released fairly promising data from its trial for the gene therapy PF-06939926 in boys with Duchenne muscular dystrophy. As the long code name implies, . . .
Posted on 5/18/20
Can Pfizer's Stock Keep Climbing?
The big news regarding Pfizer (NYSE:PFE) these days centers on its search for a COVID-19 vaccine, but that just obscures more important news for investors. This . . .
Posted on 5/18/20
Teladoc Health Upsizes, Prices Convertible Notes Issue
Teladoc Health (NYSE:TDOC) stands to reap tens of millions of dollars more than it initially planned from an upcoming convertible senior notes issue. The company announced . . .
Posted on 5/17/20
Akers Biosciences Announces $4.8M Registered Direct Offering
Thorofare, New Jersey, (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has entered into definitive . . .
Posted on 5/17/20
TG Therapeutics Proposes Public Offering of Common Stock
NEW YORK, (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases, announced that it . . .
Posted on 5/17/20
TG Therapeutics Prices Upsized Public Offering of Common Stock
NEW YORK, (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company developing medicines for patients with B-cell mediated diseases, today announced the pricing of . . .
Posted on 5/17/20
Oyster Point Pharma Proposed Public Offering of Common Stock
PRINCETON, N.J., (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat . . .
Posted on 5/17/20
Chembio Diagnostics Closes Public Offering of Common Stock
HAUPPAUGE, N.Y., (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced today the closing of its previously . . .
Posted on 5/17/20
TG Therapeutics Provides Business Update
NEW YORK, (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the first quarter ended March 31, 2020 and recent company . . .
Posted on 5/17/20
ArTara Therapeutics Announces Corporate Name Change to Protara Therapeutics
NEW YORK, (GLOBE NEWSWIRE) -- ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty diseases, today . . .
Posted on 5/15/20
Merck Just Made a Gamble That Smart Investors Should Bet on Too
While its blockbuster cancer therapeutic Keytruda continues to excite pharma investors, a piece of equally important news is that Merck (NYSE:MRK) is in the midst of . . .
Posted on 5/15/20
Merck's Top Cancer Therapy Takes Another Big Leap Forward
Breast cancer patients with particularly aggressive tumor profiles were treated to some good news on Thursday. Clinical trial results from Merck (NYSE:MRK) showed that adding Keytruda . . .
Posted on 5/15/20
Teladoc Health Aims to Raise $800 Million With Convertible Notes Issue
In a business maneuver that is becoming extremely common during these chaotic economic times, Teladoc Health (NYSE:TDOC) is aiming to raise some capital through an issue . . .
Posted on 5/14/20
Citius Announces $7.5M Registered Direct Offering
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced that it has entered into . . .
Posted on 5/14/20
Wedgewood Pharmacy to Acquire 503B Outsourcing Facility
SWEDESBORO, N.J.--(BUSINESS WIRE)--Wedgewood Pharmacy has reached a definitive agreement to purchase the San Jose, California-based assets of Leiters Enterprises. These assets comprise the equipment and facilities . . .
Posted on 5/14/20
New Jerseyans Get New Mental Health & Addiction Treatment Options, Eleanor Health Expands to NJ
Eleanor Health, an addiction and mental health services provider designed to deliver whole-person, long-term treatment for substance use focused on patient recovery outcomes and modeled on . . .
Posted on 5/14/20
HOOKIPA Pharma Reports First Quarter 2020 Financial Results and Provides a Corporate Update
NEW YORK and VIENNA, Austria, May 14, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting . . .
Posted on 5/14/20
Carlyle Portfolio Company Net Health Acquires Tissue Analytics
Net Health, a premier provider of cloud-based Electronic Health Record (EHR) software for specialized care settings, today announced that it has acquired Tissue Analytics
Posted on 5/14/20
Is Bristol Myers Squibb Losing Its Edge As A Growth Stock?
Despite soundly beating revenue forecasts last quarter, Bristol Myers Squibb (NYSE:BMY) was forced to delay its chimeric antigen receptor T-cell (CAR-T) immunotherapy after the Food and . . .
Posted on 5/14/20
Bristol Myers Squibb Receives a 'Refuse to File' Letter for an Experimental Cancer Therapy on a Deadline
Critically ill patients with multiple myeloma will need to wait a lot longer for an experimental new cancer therapy from Bristol Myers Squibb (NYSE:BMY) and bluebird . . .
Posted on 5/13/20
PM Pediatrics Hits Milestone 10,000 COVID-19 PCR and Antibody Tests Administered to Kids and Families
PM Pediatrics, the nation’s largest provider of pediatric urgent care, today announced it has conducted more than 10,000 COVID-19 PCR and antibody tests in the last . . .
Posted on 5/13/20
Drug Use by State: 2020’s Problem Areas – WalletHub Study
With the stress of social distancing leading to drug use relapses or overdoses, and SAMHSA’s National Prevention Week in full swing, the personal-finance website WalletHub today . . .
New York
